SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001072613-18-000344
Filing Date
2018-05-15
Accepted
2018-05-15 16:22:34
Documents
1
Group Members
APPLE TREE PARTNERS II - ANNEX, L.P.APPLE TREE PARTNERS IV, L.P.APPLE TREE VENTURES II - ANNEX, LLCAPPLE TREE VENTURES II, L.P.ATP III GP, LTD.SETH L. HARRISON

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A - AMENDMENT NO. 3 (EXIT FILING) novus-sch13da18199.htm SC 13D/A 245827
  Complete submission text file 0001072613-18-000344.txt   247503
Mailing Address
Business Address 405 LEXINGTON AVE 54TH FLOOR NEW YORK NY 10174 6462271800
APPLE TREE PARTNERS II LP (Filed by) CIK: 0001143789 (see all company filings)

Type: SC 13D/A

Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Subject) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88334 | Film No.: 18836859
SIC: 2834 Pharmaceutical Preparations